Geoffrey E. Harris - Mar 30, 2022 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Stock symbol
VYNT
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4
Date filed
4/1/2022, 04:30 PM
Previous filing
Jan 20, 2022
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award +43.5K +523.64% 51.8K Mar 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 30, 2022, the Reporting Person was granted 43,478restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date.